Hypothermia as an adjunctive treatment for severe bacterial meningitis
- PMID: 11033098
- DOI: 10.1016/s0006-8993(00)02894-8
Hypothermia as an adjunctive treatment for severe bacterial meningitis
Abstract
Brain injury due to bacterial meningitis results in a high mortality rate and significant neurologic sequelae in survivors. The objective of this study was to determine if the application of moderate hypothermia shortly after the administration of antibiotics would attenuate the inflammatory response and increase in intracranial pressure that occurs in meningitis. For this study we used a rabbit model of severe Group B streptococcal meningitis. The first component of this study evaluated the effects of hypothermia on blood-brain barrier function and markers of inflammation in meningitic animals. The second part of the study evaluated the effects of hypothermia on intracranial pressure, cerebral perfusion pressure and brain edema. This study demonstrates that the use of hypothermia preserves CSF/serum glucose ratio, decreases CSF protein and nitric oxide and attenuates myeloperoxidase activity in brain tissue. In the second part of this study we show a decrease in intracranial pressure, an improvement in cerebral perfusion pressure and a decrease in cerebral edema in hypothermic meningitic animals. We conclude that in the treatment of severe bacterial meningitis, the application of moderate hypothermia initiated shortly after antibiotic therapy improves short-term physiologic measures associated with brain injury.
Similar articles
-
Hypothermia attenuates beta1 integrin expression on extravasated neutrophils in an animal model of meningitis.Inflammation. 2001 Jun;25(3):137-44. doi: 10.1023/a:1011044312536. Inflammation. 2001. PMID: 11403204 Free PMC article.
-
Hypothermia decreases excitatory neurotransmitter release in bacterial meningitis in rabbits.Brain Res. 1999 Nov 13;847(1):143-8. doi: 10.1016/s0006-8993(99)02120-4. Brain Res. 1999. PMID: 10564748
-
Modulation of nuclear factor-kappaB activation and decreased markers of neurological injury associated with hypothermic therapy in experimental bacterial meningitis.Crit Care Med. 2002 Nov;30(11):2553-9. doi: 10.1097/00003246-200211000-00025. Crit Care Med. 2002. PMID: 12441769
-
Drug Insight: adjunctive therapies in adults with bacterial meningitis.Nat Clin Pract Neurol. 2006 Sep;2(9):504-16. doi: 10.1038/ncpneuro0265. Nat Clin Pract Neurol. 2006. PMID: 16932615 Review.
-
Pathogenesis of bacterial meningitis.Infect Dis Clin North Am. 1999 Sep;13(3):527-48, v-vi. doi: 10.1016/s0891-5520(05)70093-3. Infect Dis Clin North Am. 1999. PMID: 10470554 Review.
Cited by
-
The Potentials of Melatonin in the Prevention and Treatment of Bacterial Meningitis Disease.Molecules. 2021 Mar 5;26(5):1419. doi: 10.3390/molecules26051419. Molecules. 2021. PMID: 33808027 Free PMC article. Review.
-
Increased cerebrospinal fluid cleaved tau protein (C-tau) levels suggest axonal damage in pediatric patients with brain tumors.Childs Nerv Syst. 2015 Aug;31(8):1313-9. doi: 10.1007/s00381-015-2705-7. Epub 2015 Apr 22. Childs Nerv Syst. 2015. PMID: 25899850
-
Group B Streptococcal Neonatal Meningitis.Clin Microbiol Rev. 2022 Apr 20;35(2):e0007921. doi: 10.1128/cmr.00079-21. Epub 2022 Feb 16. Clin Microbiol Rev. 2022. PMID: 35170986 Free PMC article. Review.
-
Phenotypic Screens Reveal Posaconazole as a Rapidly Acting Amebicidal Combination Partner for Treatment of Primary Amoebic Meningoencephalitis.J Infect Dis. 2019 Mar 15;219(7):1095-1103. doi: 10.1093/infdis/jiy622. J Infect Dis. 2019. PMID: 30358879 Free PMC article.
-
Lumbar drainage for the treatment of severe bacterial meningitis.Neurocrit Care. 2013 Oct;19(2):199-205. doi: 10.1007/s12028-013-9853-y. Neurocrit Care. 2013. PMID: 23739926
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials